1. An assessment of nationwide trends in emergency department (ED) resuscitative endovascular balloon occlusion of the aorta (REBOA) use - A trauma quality improvement program registry analysis.
- Author
-
Hanif H, Fisher AD, April MD, Rizzo JA, Miskimins R, Dubose JD, Cripps MW, and Schauer SG
- Abstract
Background: Use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for temporary hemorrhage control in severe non-compressible torso trauma remains controversial, with limited data on patient selection and outcomes. This study aims to analyze the nationwide trends of its use in the emergency department (EDs)., Methods: A retrospective analysis of the American College of Surgeons Trauma Quality Improvement Program (ACS-TQIP) from 2017 to 2022 was performed, focusing on REBOA placements in EDs., Results: The analysis included 3398 REBOA procedures. Majority patients were male (76 %) with a median age of 40 years (27-58) and injury severity score of 20 (20-41). The most common mechanism was collision (64 %), with emergency surgeries most frequently performed for pelvic trauma (14 %). Level 1 trauma centers performed 82 % of these procedures, with consistent low annual utilization (<200 facilities). Survival rates were 85 % at 1-h post-placement, decreasing significantly to 42 % by discharge., Conclusions: REBOA usage in remains limited but steady, primarily occurring at level 1 trauma center EDs. While short-term survival rates are favorable, they drop significantly by the time of discharge., Competing Interests: Declaration of competing interest Andrew D Fisher, Michael D April, Julie A Rizzo, Joseph D DuBose, and Steven G Schauer have all received funding from the Department of Defense in the form of grants to their institutions. However, there are no competing interests pertaining this particular publication., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF